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Abstract: Carcinoid bronchopulmonary tumors represent approximately 25% of all carcinoid 
tumors and 1%–2% of all lung neoplasms. The most common symptoms are: persistent cough, 
asthma-like wheezing, chest pain, dyspnea, hemoptysis and obstructive pneumonitis. We 
present a case of a young adult diagnosed with a typical carcinoid tumor. The diagnosis was 
established on the basis of imaging examination and bronchoscopic biopsy. The patient was 
treated with bronchoscopic electrocautery therapy to relieve the obstructed airway, followed 
by surgical lobectomy in order to entirely remove the exophytic damage. This approach was 
not only a palliative management to bronchial obstruction but also avoided pneumonectomy. 
Recent studies support the use of such interventional resection methods, as they may result in 
a more conservative surgical resection.
Keywords: carcinoid tumor, typical lung carcinoid, therapeutic bronchoscopy, surgical 
resection
Introduction
Carcinoid tumors develop from stem cells of the bronchial epithelium known as 
Kulchitsky cells, which have neuroendocrine activity. These neuroendocrine cells 
can develop tumors in many different organs with most common being the lungs, the 
appendix, the small intestine (duodenum), the rectum and the pancreas.1 The most recent 
classification system from the World Health Organisation categorized neuroendocrine 
pulmonary tumors in four types: typical carcinoid; atypical carcinoid (ATC); large 
cell neuroendocrine carcinoma; and small cell lung cancer.2
Carcinoid bronchopulmonary tumors represent approximately 25% of all carcinoid 
tumors and 1%–2% of all lung neoplasms.3 Approximately 70% of these tumors are 
located centrally in the large bronchial tubes leading to the lung, while 10%–20%, 
known as peripheral carcinoids, develop in the pulmonary periphery.4
Typical carcinoid pulmonary tumors manifest nine to ten times more often than 
ATC tumors. They are characterized by slow development and rare metastasis to 
other organs. Typical carcinoid tumors are seen in younger patients more often than 
ATCs and appear to be the most frequent pulmonary neoplasms during childhood 
and puberty.5,6 ATC lung tumors have a more aggressive histologic appearance and a 
greater tendency to metastasize than typical carcinoid lung tumors. These tumors are 
more frequent in males, and the average age of onset is 46 years.7
Unlike most lung cancers, the development of carcinoid pulmonary tumors is not 
related to smoking or other environmental causes (eg, tobacco smoke, air pollution, or 
asbestos). The detection of carcinoid tumorlets in lung biopsies led to speculation that 
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carcinoid tumors may grow from these cells.1 However, 
further research needs to be conducted as this association 
has not been yet determined.
Case report
A 26-year-old female presented with wheezing episodes, 
cough and mild dyspnea. After a chest x-ray revealed 
normal findings and spirometry showed mild restriction 
(Table 1), she was commenced on bronchodilators and 
inhaled c  orticosteroids. Two years later, the symptoms were 
not entirely relieved and she had developed hemoptysis of 
approximately 10 mL/24 hours. Therefore, she was referred 
to the pulmonary department for further examinations.
During clinical examination the patient had reduced 
respiratory whistling and mild wheezing in the upper left 
pulmonary field. The results of the exams revealed nor-
mal blood tests, a mild restrictive spirometry (Table 1), 
a negative Mantoux and a left perihilar shadow in the chest 
radiograph (Figure 1A and B). A chest high resolution 
co  mputed tom  ography was performed showing a nodule 
in the left primary bronchus causing its partial obstruction 
(Figure 2). The suspicion of malignancy was established and 
the patient underwent a bronchoscopy (Olympus BF-P240; 
6 mm in  sertion tube, biopsy channel 2.6 mm, 55 cm working 
length, [Olympus Corp, Tokyo, Japan]). The findings showed 
exophytic damage with increased vascularization in the left 
primary bronchus 5 cm from the carina. This picture was 
com  patible with a carcinoid tumor. The tumor was biopsied 
and the specimen was sent for histological examination. 
The biopsy demonstrated a typical carcinoid and the patient 
underwent pelvic and cerebral computed tomography, 
which both showed normal findings.
In an effort to avoid pneumonectomy, and to produce 
rapid palliation of hemoptysis and immediate tumor debulk-
ing, bronchoscopic electrocautery was selected as the most 
appropriate procedure.
A rigid bronchoscopy was inserted into the trachea 
under general anesthesia using a 7.5 mm Storz rigid 
  bronchoscope (Karl Storz Gmbh and Co, Tuttlingen, 
Germany). Electrocautery (power setting of 40 Watts, blend 
mode, normal coagulation, electrosurgical monopolar unit 
PSD-20, with foot switch, flexible monopolar electr  ocautery 
blunt probe Olympus CD-6C-1, loop snare, [Olympus, 
Tokyo, Japan]) was performed on the exophytic tumor ti  ssue 
followed by mechanical removal. This intervention fully 
re-opened the obstructed left main bronchus and the upper 
subsegment of the left upper lobe. The remaining tissue in 
the obstructed lower subsegment of the left upper lobe was 
treated by surgical resection, performing a lobectomy to 
remove the tissue entirely. During this procedure, three lymph 
nodes (subsegmental and segmental) were also removed. The 
final report stated that there was no expanding malignancy 
affecting the pleural cavity or the lymph nodes.
The patient was not given chemotherapy but was followed 
up with regular medical monitoring combined with imag-
ing studies (ie, chest x-ray, chest computed   tomography). 
Five years after surgical treatment, the patient was asymp-
tomatic with normal chest radiographs and normal spirometry 
(Table 1; Figure 1C).
Discussion
About 25% of patients with carcinoid lung tumors are 
  asymptomatic.8 The severity and variety of symptoms 
depend on the size of the carcinoid pulmonary tumor and 
the   production of hormones. In symptomatic patients 
with central carcinoids, the most common symptoms are: 
  persistent cough, asthma-like wheezing, chest pain, dyspnea, 
hemoptysis and obstructive pneumonitis.9 A number of 
studies have reported that a mistaken diagnosis of asthma is 
frequent in these cases, delaying early diagnosis. Peripheral 
carcinoid tumors rarely manifest any symptoms.
Occasionally, carcinoid pulmonary tumors may initiate 
an excessive hormonal secretion causing various neuroen-
docrine syndromes such as carcinoid syndrome and Cushing 
syndrome.9,10 The most common symptoms of carcinoid 
syndrome are: facial flushing, sweating, diarrhea, rapid 
cardiac beats and wheezing. Even more rarely, patients with 
Cushing syndrome caused by the abnormal overproduction of 
cortisol can develop muscle weakness, obesity in the upper 
body, high blood pressure, high blood sugar and increased 
body and facial hair.
Almost 90% of typical carcinoid tumors are diagnosed 
at an early stage while more than 50% of ATC tumors are 
diagnosed at stage II or III.11 The diagnosis of carcinoid 
pulmonary tumor is established on the basis of the patient’s 
symptoms combined with imaging examination such as chest 
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Table 1 Spirometries performed pre- (first visit, upon diagnosis) 
and post-operatively (after treatment)
First visit Upon  
diagnosis
After  
treatment
FVC 2.25/61% 2.04/55.6% 3.50/95.3%
FEV1 (L), %Pred 2.10/66.7% 1.93/61.3% 3.20/101.6%
FEV1/FVC  
(Measured/predicted)
0.93/0.87 0.95/0.87 0.91/105.5
Abbreviations:  FVC,  forced  vital  capacity;  FEV1,  forced  expiratory  volume  in 
1 second; %Pred, percentage of predicted normal value.Journal of Multidisciplinary Healthcare 2012:5
radiography, computed tomography and magnetic resonance 
imaging.12 To verify the histologic type of the pulmonary 
tumor detected, there are several biopsy options including 
bronchoscopic biopsy, needle biopsies and surgical biopsies 
(eg, thoracotomy).13 However, it has been reported that 
  bronchoscopic biopsy has a risk of hemorrhage, especially 
in cases of partial or total removal of vascular tumors.14
The primary and most effective treatment for all 
  pulmonary carcinoid tumors is surgical resection as long 
as no contraindications to surgery exist (eg, widespread 
metastatic disease).15 Chemotherapy and radiotherapy have 
no therapeutic contribution and there is no verified optimal 
therapy for unresectable carcinoid lung tumors.16
There are a variety of resection techniques that treat lung 
carcinoids effectively.13 Presently, the most commonly   utilized 
resection procedure is lobectomy. For smaller tumors located 
in the periphery or within a pulmonary se  gment,   surgeons 
may perform segmental resection or wedge r  esection. Sleeve 
resection is usually performed for central lesions. In rare 
cases, a bilobectomy or pneumonectomy may be required 
due to the size or the location of the tumor. Postoperatively, 
the most common complications are excessive bleeding, 
atelectasis and   prolonged air leak.13
Interventional therapeutic bronchoscopies such as 
laser bronchoscopy, electrocautery therapy, cryotherapy, 
e  ndobronchial brachytherapy, photodynamic therapy and 
airway stents may also be performed in certain cases.17,18 
Nd-YAG lasers and electrocautery, together with mechani-
cal tumor removal, are more appropriate for rapid pal-
liation and immediate tumor debulking.19 In particular, 
elect  rocautery therapy, as applied in our case, can achieve 
immediate relief of the symptoms resulting from obstructed 
airways in 55%–75% of patients. Its advantages over laser 
t  reatment include cost effectiveness, higher availability, 
A B C D
Figure 1 Chest radiographs: (A and B) before treatment with arrow showing a left perihilar shadow, (C) After treatment (surgery) arrow indicates (D) staples on 5-year follow up.
Figure 2 Chest HRCT showing nodule development in the left primary bronchus causing its partial obstruction (arrow) before treatment. 
Abbreviation: HRCT, high resolution computed tomography.
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and faster removal of tumors and components resistant 
to laser   coagulation.18 Moreover, in a study evaluating 
the degree of damage and bronchial wall healing after 
photodynamic,   Nd-YAG laser, and electrocautery therapy, 
electrocautery produced the least amount of airway scarring 
and s  ubepithelial fibrosis.19 In another study, the amount 
of mucosal damage visualized after electrocautery was 
correlated with histologic tissue damage. The investigators 
concluded that this is a potential advantage of electrocau-
tery compared to other therapies, where the real histologic 
damage may be more severe than what is v  isualized after 
the therapy.20 Side effects of elec  trocautery therapy include 
burn, haemorrhage, and inadvertent electrical shock to the 
endoscopist or the patient, but there are no reports of treat-
ment-related deaths or respiratory failure episodes.18,21
These bronchoscopic techniques are usually used for 
palliative management of bronchial obstruction, for mass 
reduction prior to surgery, or for patients unsuitable for 
formal surgery.18 A number of studies of endobronchial 
resection have confirmed that bronchoscopic techniques 
are successful modalities of treatment.22 Several therapeutic 
modalities used in conjunction may be essential to achieve the 
best management of the disease, rather than a single invasive 
approach.23 In a recent review, even though 50% of patients 
underwent a lung resection after a single bronchoscopic 
resection, the authors reported that the inability to remove 
the remaining tumor was entirely due to the inaccessibility 
of the tumor.24–26 Some experts believe that tumor reduction 
by this method may result in a more conservative surgical 
resection.15 Our study confirms these findings as the use of 
bronchoscopic electrocautery followed by surgical lobec-
tomy not only removed the tumor entirely but also avoided 
pneumonectomy.
Among pulmonary malignancies, carcinoid tumors have 
the highest prognostic rates. Typical carcinoid tumors have 
better prognoses than the atypical forms. The 5-year survival 
rate reaches 92%–100% for typical lung carcinoids and only 
61%–88% for ATCs.27 Previous studies have shown that 
lymph node involvement as well as the presence of tumorlets, 
have significant negative effects on prognoses.28
Early suspicion, combined with imaging examination 
and biopsy, is the key to diagnosis. Improved surgical tech-
niques allow smaller incisions resulting in shorter hospital-
ization and less postoperative pain.19 Many studies suggest 
that the use of endobronchial management techniques not 
only improve clinical symptoms and quality of life, but 
also increase overall survival.21,23 Therefore, performing 
less invasive procedures should be considered throughout 
the management of lung cancer patients, provided no poor 
prognostic factors exist.29 Series utilizing this mode of 
therapy must be reported in order to determine long-term 
outcomes.
A carcinoid tumor may be considered a challenging 
  disease due to its infrequency. It is very important that 
scientists continue to investigate and publish results from 
such cases so that new information about the etiology and 
treatment of the disease can be made available.
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